XML 65 R55.htm IDEA: XBRL DOCUMENT v3.23.1
Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Earnings Per Share [Abstract]    
Net loss attributable to Adaptive Biotechnologies Corporation $ (57,699) $ (62,736)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic 143,511,142 141,697,252
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic $ (0.40) $ (0.44)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted 143,511,142 141,697,252
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted $ (0.40) $ (0.44)